159 stories from 19 sources
The week in Medicine and Healthcare
Click on a headline to see stories that shaped it.
Threads
8 threads
Ebola expanded across Nigeria, Kenya, Uganda, and other linked settings as Kenya recorded household transmission and authorities widened quarantine and contact tracing. A vaccine trial in Congo added a longer-term effort to strengthen outbreak preparedness.
Moderna and Merck moved from awaiting full results to reporting that their personalized mRNA vaccine reduced melanoma recurrence and delayed distant spread. The clinically positive findings nevertheless triggered a biotech selloff because investors expected a larger commercial breakthrough.
Reports showed healthcare costs rising for workers and families, with employer-sponsored family premiums reaching $28,303 and more insured people skipping care because of expense. The pressure extends beyond premiums to household budgets and access to treatment.
The United States recorded a third measles death as cases surpassed 4,400, while recurring coverage tied outbreaks to vaccination gaps, public trust, and electoral pressure. The issue increasingly links disease control to partisan accountability.
Research connected a rare protective mutation with reduced Alzheimer’s damage, while other studies explored steps, sleep, and approaches that target brain injury without removing toxic tau. Together, the findings broadened the field’s possible prevention and treatment strategies.
Accounts from Gaza described hospitals struggling with damage, shortages, and overwhelmed services, while breast cancer patients faced worsening delays in care. The recurring reports show the conflict eroding both emergency capacity and routine treatment.
A federal judge heard a challenge to Medicaid work requirements as states prepared to track work and exemptions. The policy could reduce coverage through administrative failures, while a proposed reprieve for 200,000 Bronx residents underscored its immediate local stakes.
Massachusetts moved to seize the licenses of RegalCare nursing homes after findings of sharply reduced care quality. A separate report indicated that regulators were allowing another operator’s quality problems to continue, intensifying scrutiny of state oversight.
Day’s Recap